• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

amg-232

  1. What happened to Amg-232?

    It looks like there are clinical trials still running for amg-232, but it has been dropped from the pipeline page on the website. Does anyone know why?